Information Journal Paper
APA:
Copy. (2017). Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells. Toxicology In Vitro, 38(-), 117-123. SID. https://sid.ir/paper/721984/en
Vancouver:
Copy. Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells. Toxicology In Vitro[Internet]. 2017;38(-):117-123. Available from: https://sid.ir/paper/721984/en
IEEE:
Copy, “Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells,” Toxicology In Vitro, vol. 38, no. -, pp. 117–123, 2017, [Online]. Available: https://sid.ir/paper/721984/en